论文部分内容阅读
30例应用阿霉素行膀胱内灌注预防复发随访平均33.2月。2例复发,复发率为7.7%,治疗过程中未发现全身副反应,仅2例出现局部症状。
30 cases of doxorubicin intravesical instillation to prevent recurrence followed up an average of 33.2 months. 2 cases relapsed, the recurrence rate was 7.7%. No systemic side effects were found during the course of treatment, and only 2 cases showed local symptoms.